Niche biotech focus IGAN Biosciences is a small IT services and consulting firm with a biotech origin focused on IgA nephropathy treatments. This creates opportunities to offer specialized IT solutions that support research, regulatory submissions, and clinical data management for biotech clients.

Early-stage footprint With a lean team (2-10 employees) and annual revenue under a million, IGAN is likely seeking cost-efficient IT partnerships, cloud hosting, security hardening, and outsourced development to scale without committing to large, long-term contracts.

Security posture The presence of security headers such as HSTS and X-XSS-Protection in their tech stack indicates a focus on web application security, suggesting interest in enhanced security services, compliance automation, and secure cloud architecture for health data projects.

Biotech market alignment IGAN’s origins in academic research and its disease focus align with partnerships or outsourcing opportunities with mid to small biotech firms that require IT support for data management, analytics, and collaboration tools tailored to clinical research workflows.

Growth and partnerships Although revenue is below $1M, IGAN’s connection to Tufts University and niche therapeutic area positions it for collaboration with larger pharma players or contract research organizations seeking specialized IT services for niche nephrology programs.